Human MutS homologue MSH4 physically interacts with von Hippel-Lindau tumor suppressor-binding protein 1

被引:0
|
作者
Her, C
Wu, XL
Griswold, MD
Zhou, F
机构
[1] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA
[2] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA
[3] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Increasing evidence indicated that the protein factors involved in DNA mismatch repair (MMR) possess meiotic functions beyond the scope of DNA mismatch correction. The important roles of MMR components in meiotic processes have been highlighted by the recent identification of two additional members of the mammalian MutS homologs, MSH4 and MSH5. Mammalian MSH4 and MSH5 proteins form a heterodimeric complex and play an important role in the meiotic processes. As a step forward to the understanding of the molecular mechanisms underlying the roles of these two mammalian MutS homologues, here we have identified von Hippel-Lindau (VHL) tumor suppressor-binding protein 1 (VBP1) as an interacting protein partner for human MSH4 (hMSH4). In addition, we have characterized a hMSH4 splicing variant (hMSH4sv) encoding a truncated form of hMSH4. The protein encoded by hMSH4sv was unable to interact with hMSH5, but it retained the capacity to interact with VBP1. It is conceivable that hMSH4 and hMSH4sv can carry out different but overlapping functions by differential protein interactions, and, therefore, bMSH4sv might represent a separation-of-function alternative form of the hMSH4 protein. hMSH4 and VBP1 proteins were colocalized in mammalian cells. Three-hybrid analysis suggested that VBP1 could compete with hMSH5 for the binding of hMSH4. Thus, hMSH4 may be involved in diverse cellular processes through interaction with different protein partners, and the levels of VBP1 protein expression in cells could potentially affect the availability of the hMSH4-hMSH5 hetero-complex.
引用
收藏
页码:865 / 872
页数:8
相关论文
共 50 条
  • [1] The von Hippel-Lindau tumor suppressor protein
    Ivan, M
    Kaelin, WG
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2001, 11 (01) : 27 - 34
  • [2] The von Hippel-Lindau Tumor Suppressor Protein
    Kaelin, William G.
    ANNUAL REVIEW OF CANCER BIOLOGY, VOL 2, 2018, 2 : 91 - 109
  • [3] The von Hippel-Lindau tumor suppressor protein: An update
    Kaelin, William G., Jr.
    OXYGEN BIOLOGY AND HYPOXIA, 2007, 435 : 371 - 383
  • [4] The interaction of the von Hippel-Lindau tumor suppressor and heterochromatin protein 1
    Lai, Yanlai
    Song, Meihua
    Hakala, Kevin
    Weintraub, Susan T.
    Shiio, Yuzuru
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2012, 518 (02) : 103 - 110
  • [5] The von Hippel-Lindau tumor suppressor protein and kidney cancer
    Kaelin, William G., Jr.
    MEDICINA-BUENOS AIRES, 2007, 67 : 6 - 10
  • [7] The Elongin BC complex and the von Hippel-Lindau tumor suppressor protein
    Conaway, JW
    Kamura, T
    Conaway, RC
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1998, 1377 (02): : M49 - M54
  • [8] Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
    Cockman, ME
    Masson, N
    Mole, DR
    Jaakkola, P
    Chang, GW
    Clifford, SC
    Maher, ER
    Pugh, CW
    Ratcliffe, PJ
    Maxwell, PH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) : 25733 - 25741
  • [9] The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma
    Kaelin, William G., Jr.
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 680S - 684S
  • [10] Isoform-specific interactions of the von Hippel-Lindau tumor suppressor protein
    Giovanni Minervini
    Gabriella M. Mazzotta
    Alessandro Masiero
    Elena Sartori
    Samantha Corrà
    Emilio Potenza
    Rodolfo Costa
    Silvio C. E. Tosatto
    Scientific Reports, 5